TABLE A2–1 Incidence of Chlamydia in Men and Women
|
Age Groups |
Male Population |
Incidence Rates (per 100,000) |
Cases |
|
<1 |
2,030,000 |
0.00 |
0 |
|
1–4 |
8,314,000 |
120.28 |
10,000 |
|
5–14 |
19,502,000 |
461.49 |
90,000 |
|
15–24 |
18,516,000 |
6,480.88 |
1,200,000 |
|
25–34 |
20,835,000 |
2,879.77 |
600,000 |
|
35–44 |
20,911,000 |
334.75 |
70,000 |
|
45–54 |
14,777,000 |
135.35 |
20,000 |
|
55–64 |
10,101,000 |
99.00 |
10,000 |
|
65–74 |
8,420,000 |
0.00 |
0 |
|
75–84 |
4,274,000 |
0.00 |
0 |
|
≥85 |
1,005,000 |
0.00 |
0 |
|
Total |
128,685,000 |
1,554.18 |
2,000,000 |
|
Age Groups |
Female Population |
Incidence Rates (per 100,000) |
Cases |
|
<1 |
1,933,000 |
0.00 |
0 |
|
1–4 |
7,905,000 |
126.50 |
10,000 |
|
5–14 |
18,554,000 |
485.07 |
90,000 |
|
15–24 |
17,747,000 |
6,761.71 |
1,200,000 |
|
25–34 |
20,835,000 |
2,879.77 |
600,000 |
|
35–44 |
21,238,000 |
329.60 |
70,000 |
|
45–54 |
15,447,000 |
129.47 |
20,000 |
|
55–64 |
11,140,000 |
89.77 |
10,000 |
|
65–74 |
10,544,000 |
0.00 |
0 |
|
75–84 |
6,814,000 |
0.00 |
0 |
|
85+ |
2,593,000 |
0.00 |
0 |
|
Total |
134,750,000 |
1,484.23 |
2,000,000 |
Health consequences of chlamydia infection in women accounted for in the model include acute urethral syndrome, mild cervicitis, pelvic inflammatory disease (PID) and its sequelae (ectopic pregnancy, chronic pelvic pain, and infertility, assumed for calculation purposes to incur costs and decreased health states with a 5-year lag from infection), Reiter’s syndrome, and arthritis. Table A2–2 illustrates the estimated number of cases in each state, the duration of time that state is experienced, and the health utility index (HUI) associated with each state. These vary greatly. At one end of the spectrum are a large number of relatively minor conditions such as acute urethral syndrome (100,000 cases experiencing three days of an HUI of .75). At the other end are many fewer